“以患者为中心”的理念已成为当前药物研发的核心指导思想。“以患者为中心”的药物研发是指基于患者角度开展的药物研发、设计、实施和决策的过程,旨在高效…
Han Kun is a leading full-service law firm in China, and has been widely recognized as a leader in complex cross-border and domestic transactions and compliance matters. Our main practice areas include private equity, mergers and acquisitions, international and domestic capital markets, investment funds, asset management, compliance, banking and finance, aviation finance, foreign direct investment, antitrust/competition, data protection, private client/wealth management, intellectual property, bankruptcy and restructuring and dispute resolution. For further details, please visit our official website at: www.hankunlaw.com/en/
